HRT in Trouble

November 15, 2002

San Francisco - Despite the unexpected finding that combined use of oral conjugated equine estrogens (CEE) and oral medroxyprogesterone acetate (MPA) actually raises a healthy menopausal women's risk of coronary heart disease, and that it increases invasive breast cancer risk, gynecologist Susan Ballagh, M.D., remains a proponent of the popular regimen for appropriate patients.